{"id":22681,"date":"2023-01-10T09:58:57","date_gmt":"2023-01-10T08:58:57","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=22681"},"modified":"2023-01-10T10:07:08","modified_gmt":"2023-01-10T09:07:08","slug":"andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/","title":{"rendered":"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension"},"content":{"rendered":"

SoniVie Ltd. (“SoniVie” or the “Company”), a medical device company developing a proprietary solution to treat hypertension, announced today the completion of a $60 million series C round financing. The financing was led by Andera Partners, with participation from Supernova Invest and Omega Funds. Current SoniVie shareholder TechWald also participated.<\/p>\n

In conjunction with the financing, the Company appointed two renowned medtech experts to its Board of Directors, Raymond W. Cohen and Zeev Zehavi, as independent directors.<\/p>\n

SoniVie has developed an ultrasound-based denervation technology with application in multiple therapeutic areas. TIVUS\u2122 (Therapeutic Intra-Vascular Ultrasound System) employs high-frequency non-focused ultrasound energy to ablate nerves in the renal artery to decrease blood pressure. This minimally invasive investigational procedure can be used to treat patients suffering from hypertension, which impacts millions of people worldwide and substantially increases their risk of heart attack, stroke and kidney failure.<\/p>\n

The proceeds from SoniVie financing are envisioned to be used to reach clinical and regulatory milestones and to support TIVUS\u2122 renal artery denervation program.<\/p>\n

Following this financing, the Board of Directors of the Company is chaired by Zvika Slovin and composed of directors appointed by Andera Partners (Rapha\u00ebl Wisniewski), Omega Funds (Claudio Nessi), Supernova Invest (R\u00e9mi Spagnol) and TechWald Holding (Alessandro Piga), Sonivie CEO Tomaso Zambelli and independent directors Raymond W. Cohen (CEO of Axonics) and Zeev Zehavi (former executive JJDC).<\/p>\n

“We are very pleased that this financing round concluded with such a resounding success” said Tomaso Zambelli, CEO of SoniVie Ltd<\/strong>. “The new investors and the Board of Directors bring significant experience to the Company in the field of Renal Denervation for Hypertension”.<\/p>\n

Rapha\u00ebl Wisniewski of Andera Partners<\/strong> commented, “SoniVie TIVUS\u2122 has the potential to provide patients and physicians with a safe, efficient and easy to use device. We are thrilled to support this talented management together with our syndicate partners and our new board members”.<\/p>\n","protected":false},"excerpt":{"rendered":"

SoniVie Ltd. (“SoniVie” or the “Company”), a medical device company developing a proprietary solution to treat hypertension, announced today the completion of a $60 million series C round financing. The financing was led by Andera Partners, with participation from Supernova Invest and Omega Funds. Current SoniVie shareholder TechWald also participated. In conjunction with the financing,…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[123],"class_list":["post-22681","post","type-post","status-publish","format-standard","hentry","category-biodiscovery-en"],"acf":[],"yoast_head":"\nAndera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"SoniVie Ltd. (“SoniVie” or the “Company”), a medical device company developing a proprietary solution to treat hypertension, announced today the completion of a $60 million series C round financing. The financing was led by Andera Partners, with participation from Supernova Invest and Omega Funds. Current SoniVie shareholder TechWald also participated. In conjunction with the financing,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-10T08:58:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-10T09:07:08+00:00\" \/>\n<meta name=\"author\" content=\"Nicolas Delsert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Delsert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/\"},\"author\":{\"name\":\"Nicolas Delsert\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\"},\"headline\":\"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension\",\"datePublished\":\"2023-01-10T08:58:57+00:00\",\"dateModified\":\"2023-01-10T09:07:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/\"},\"wordCount\":328,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/\",\"url\":\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/\",\"name\":\"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"datePublished\":\"2023-01-10T08:58:57+00:00\",\"dateModified\":\"2023-01-10T09:07:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anderapartners.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\",\"name\":\"Nicolas Delsert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"caption\":\"Nicolas Delsert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/","og_locale":"en_US","og_type":"article","og_title":"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension - ANDERA PARTNERS","og_description":"SoniVie Ltd. (“SoniVie” or the “Company”), a medical device company developing a proprietary solution to treat hypertension, announced today the completion of a $60 million series C round financing. The financing was led by Andera Partners, with participation from Supernova Invest and Omega Funds. Current SoniVie shareholder TechWald also participated. In conjunction with the financing,...","og_url":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2023-01-10T08:58:57+00:00","article_modified_time":"2023-01-10T09:07:08+00:00","author":"Nicolas Delsert","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicolas Delsert","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/"},"author":{"name":"Nicolas Delsert","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c"},"headline":"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension","datePublished":"2023-01-10T08:58:57+00:00","dateModified":"2023-01-10T09:07:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/"},"wordCount":328,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"articleSection":["andera Life Sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/","url":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/","name":"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"datePublished":"2023-01-10T08:58:57+00:00","dateModified":"2023-01-10T09:07:08+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/de\/andera-partners-invests-in-sonivie-a-medtech-company-developing-a-promising-device-for-the-treatment-of-hypertension\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anderapartners.com\/en\/"},{"@type":"ListItem","position":2,"name":"Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c","name":"Nicolas Delsert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","caption":"Nicolas Delsert"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/22681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/comments?post=22681"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/22681\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media?parent=22681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/categories?post=22681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}